Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Up 100.0% in May

Starpharma Holdings Limited (OTCMKTS:SPHRYGet Rating) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totalling 200 shares, a growth of 100.0% from the April 30th total of 100 shares. Based on an average trading volume of 1,200 shares, the days-to-cover ratio is currently 0.2 days.

Starpharma Price Performance

Shares of OTCMKTS:SPHRY remained flat at $2.90 on Friday. The company’s 50-day moving average is $3.12 and its 200 day moving average is $3.55. Starpharma has a 1-year low of $2.90 and a 1-year high of $5.77.

About Starpharma

(Get Rating)

Starpharma Holdings Ltd. engages in the research and development of dendrimer products for pharmaceutical, life science and other applications. The firm’s programs include: VivaGel portfolio, Drug delivery and Agrochemicals, which develops a number of products internally and others via commercial partnerships.

Featured Stories

Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.